Human FDC express PrPc invivo and invitro
Author(s) -
Caroline Thielen,
Nadine Antoine,
France Mélot,
Jean-Yves Cesbron,
Ernst Heinen,
Rikiya Tsunoda
Publication year - 2001
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2001/45454
Subject(s) - in vitro , in vivo , microbiology and biotechnology , biology , genetics
Prion diseases are fatal neurodegenerative disorders caused by accumulation of abnormal prion protein (protease-resistant prion, PrPres). PrPres accumulation is also detected in lymphoid organs after peripheral infection. Several studies suggest that follicular dendritic cells (FDC) could be the site of PrPres retention and amplification. Here we show that human follicular dendritic cells can express normal cellular prion protein (PrPc) both in situ and in vitro. When tonsillar cryosections were treated with anti-PrP antibody, the label was found on some very delicate cell extensions inside the lymphoid follicles, especially in the germinal centres. These extensions react with DRC1 antibody, used frequently to label FDC. Other structures labelled with anti-PrP antibody were the keratinocytes. To confirm the ability of FDC to synthesise PrPc, we isolated FDC by a non-enzymatic procedure and cultured them. By cytochemistry and flow cytometry it was clearly shown that FDC do produce PrPc.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom